Eloxx Pharmaceuticals Stock Forecast, Price & News

Eloxx Pharmaceuticals (NASDAQ:ELOX) Frequently Asked Questions

Is Eloxx Pharmaceuticals a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Eloxx Pharmaceuticals stock.
View analyst ratings for Eloxx Pharmaceuticals or view top-rated stocks.

How has Eloxx Pharmaceuticals' stock been impacted by COVID-19?

Eloxx Pharmaceuticals' stock was trading at $2.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ELOX stock has decreased by 75.7% and is now trading at $0.70.
View which stocks have been most impacted by COVID-19.

Are investors shorting Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 639,100 shares, a decline of 25.0% from the September 30th total of 852,300 shares. Based on an average daily trading volume, of 547,100 shares, the short-interest ratio is currently 1.2 days. Currently, 2.1% of the shares of the stock are short sold.
View Eloxx Pharmaceuticals' Short Interest.

When is Eloxx Pharmaceuticals' next earnings date?

Eloxx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, March 10th 2022.
View our earnings forecast for Eloxx Pharmaceuticals.

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.11) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.14) by $0.03.
View Eloxx Pharmaceuticals' earnings history.

What price target have analysts set for ELOX?

4 Wall Street analysts have issued 1-year price objectives for Eloxx Pharmaceuticals' shares. Their forecasts range from $1.00 to $5.00. On average, they anticipate Eloxx Pharmaceuticals' share price to reach $3.28 in the next year. This suggests a possible upside of 367.9% from the stock's current price.
View analysts' price targets for Eloxx Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the following people:

• Sumit Aggarwal, President, Chief Executive Officer & Director
• Daniel E. Geffken, Chief Financial & Accounting Officer
• Vijay Modur, Head-Research & Development
• Ali Hariri, Chief Medical Officer
• Barbara Ryan, Investor Relations Contact

What is Robert E. Ward's approval rating as Eloxx Pharmaceuticals' CEO?

2 employees have rated Eloxx Pharmaceuticals CEO Robert E. Ward on Glassdoor.com. Robert E. Ward has an approval rating of 49% among Eloxx Pharmaceuticals' employees. This puts Robert E. Ward in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Eloxx Pharmaceuticals' key competitors?

Some companies that are related to Eloxx Pharmaceuticals include iSpecimen (ISPC), Auxly Cannabis Group (CBWTF), Science 37 (SNCE), Bioqual (BIOQ), AIkido Pharma (AIKI), AIkido Pharma (AIKI), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), ProMIS Neurosciences (ARFXF), Vitality Biopharma (VBIO), U.S. Stem Cell (USRM), Protalex (PRTX), DNAPrint Genomics (DNAG), Affinity Energy and Health (ALGXY) and Deltagen (DGEN).
View all of ELOX's competitors.

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the NASDAQ under the ticker symbol "ELOX."

Who are Eloxx Pharmaceuticals' major shareholders?

Eloxx Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Altium Capital Management LP (1.30%), Geode Capital Management LLC (0.90%), Two Sigma Advisers LP (0.82%), BlackRock Inc. (0.57%), Vanguard Capital Wealth Advisors (0.51%) and Two Sigma Investments LP (0.37%). Company insiders that own Eloxx Pharmaceuticals stock include Pontifax Management 4 GP (20 and Rajesh B Parekh.
View institutional ownership trends for Eloxx Pharmaceuticals.

Which institutional investors are selling Eloxx Pharmaceuticals stock?

ELOX stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, and Citadel Advisors LLC.
View insider buying and selling activity for Eloxx Pharmaceuticals or view top insider-selling stocks.

Which institutional investors are buying Eloxx Pharmaceuticals stock?

ELOX stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Altium Capital Management LP, Vanguard Capital Wealth Advisors, BlackRock Inc., Geode Capital Management LLC, Two Sigma Investments LP, Natixis, and Bank of New York Mellon Corp. Company insiders that have bought Eloxx Pharmaceuticals stock in the last two years include Pontifax Management 4 GP (20, and Rajesh B Parekh.
View insider buying and selling activity for Eloxx Pharmaceuticals or or view top insider-buying stocks.

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $0.70.

How much money does Eloxx Pharmaceuticals make?

Eloxx Pharmaceuticals has a market capitalization of $60.38 million. The company earns $-34.58 million in net income (profit) each year or ($1.02) on an earnings per share basis.

How many employees does Eloxx Pharmaceuticals have?

Eloxx Pharmaceuticals employs 25 workers across the globe.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is www.eloxxpharma.com.

Where are Eloxx Pharmaceuticals' headquarters?

Eloxx Pharmaceuticals is headquartered at 950 WINTER STREET, WALTHAM MA, 02451.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at (781) 577-5300, via email at [email protected], or via fax at 908-864-4440.